Optima Health Plc · LSE:OPT
Optima Health — FY2026 Earnings Presentation
24 slides from Optima Health's earnings presentation, Aug 17, 2026
Slide 1: FY26 – Financial Results
FY26 – Financial Results 17 August 2026
Slide 2: Agenda
Agenda FY26 Financial Headlines 01 Jonathan Thomas Strategic Progress & Outlook 02 Jonathan Thomas Jonathan Thomas Chief Executive Officer Financial Review 03 Andy Bones Q&A 04 Open Q&A session Andy Bones Interim Chief Financial Officer 2 16/08/2026 Optima Health | Commercial in Confidence
Slide 3: Occupational Health & Wellbeing
Occupational Maintenance of Driving positive optimal health workplace wellbeing Health & Wellbeing Maximising performance & Fitness for role attendance The UK’s leading provider by size of technology enabled corporate health and wellbeing solutions Health risk Adaptation of work management & Work Em
Slide 4: Key Fundamental Strengths Enable Optima to Benefit from these Positive Market Dynamics and Capability
Key Fundamental Strengths Enable Optima to Benefit from these Positive Market Dynamics and Capability Integrated ‘Workplace Health’ model delivers Comprehensive holistic range of services Delivery via a flexible, nationwide (UK&I) sector, (OH, Mental Health, MSK, leveraged, digitally- geographic and
Slide 5: Track Record of Scaling in the UK Occupational Health Market
Track Record of Scaling in the UK Occupational Health Market Optima: Rev £70m, Integration activity Post IPO 3 further AFRS contract EBITDA £10m completed acquisitions preparation Sold to Marlowe plc delivering consistent completed adding and delivering 6.5x operating model ~£17m revenue and impleme
Slide 6: FY26 Financial Headlines
FY26 Financial Headlines Jonathan Thomas 6 16/08/2026 Optima Health | Commercial in Confidence
Slide 7: FY26 Financial Headlines
FY26 Financial Headlines FY26: £120.6m (FY25: £105.0m) FY26: £20.1m (FY25: £17.6m) Continued strong growth over the prior year with Adjusted Acquisitions integrated and delivering corporate Revenue revenues 15% ahead year on year margins, operational transformation initiatives EBITDA1 announced in D
Slide 8: Strategic Outlook & Progress
Strategic Outlook & Progress Jonathan Thomas 8 16/08/2026 Optima Health | Commercial in Confidence
Slide 9: Target to Grow Business to >£200m Revenue and >£40m EBITDA underpinned by key in-flight Strategic Initiatives
Target to Grow Business to >£200m Revenue and >£40m EBITDA underpinned by key in-flight Strategic Initiatives 4. Overhead 3. M&A Efficiencies • Consolidation • Optimise 2. Operational overhead and of UK market - 1. Organic Transformation buy and build central Medium term progress functions Growth •
Slide 10: Progress and Outlook
Progress and Outlook Progress to Date Plans for next period • Operational transformation initiatives now delivering impact through • Continued momentum and delivery against our strategic plan to 7 workstreams; deliver £200m revenues and £40m adjusted EBITDA – Clinical efficiency; Self-service & Cont
Slide 11: Combination in key KPI’s & Integration Approach
Combination in key KPI’s & Integration Approach Integration Approach: Combination Optima has identified significant areas of Talent stratification and single leadership governance synergies from the established. + = £188m Proforma combination Revenue £121m £67m • Corporate costs and shared corporate
Slide 12: One Optima Roadmap and Delivery Horizons
One Optima Roadmap and Delivery Horizons Strategy and Early Governance Scale & Value Establish the AFRS planned • Discovery, strategy & design • Unlock steady state foundational service phase across approximately efficiencies and capture 12 projects integrated state by commencement long term synergi
Slide 13: Financial Review
Financial Review Andy Bones 13 16/08/2026 Optima Health | Commercial in Confidence
Slide 14: Financials – Statement of Comprehensive Income
Financials – Statement of Comprehensive Income Statement of Comprehensive Income FY26 FY25 • Revenue £m £m – Strong progress made with revenue growth of 15% when compared to FY25, driven by acquisitions, organic wins in core markets and success in adjacencies Revenue 120.6 105.0 Cost of sales (85.3)
Slide 15: Exceptional Costs
Exceptional Costs Exceptional costs in FY 2026 of £4.7million Classification of exceptional costs • Acquisition Costs £3.2 million: • Retention of Integration and Change Team to deliver both – External advisor and legal costs relating directly to the new customer transitions and bolt on M&A integrat
Slide 16: Financials – Statement of Financial Position
Financials – Statement of Financial Position Statement of Financial Position • Strong balance sheet supporting enlarged group – Net assets of £169.8m at 31 March 2026, compared with £168.1m at 31 March 2025 31-Mar-26 31-Mar-25 – Total assets increased to £356.0m from £218.1m, principally reflecting
Slide 17: Financials – Cashflow and Net Debt
Financials – Cashflow and Net Debt Cash Flow and Net Debt • Strong operating cash generation FY26 FY25 £m £m – £17.3m cash generated from operations, up from £5.4m in FY25 – £22.0m before acquisition, integration, demerger and restructuring costs Adjusted EBITDA 20.1 17.6 Restructuring, demerger, li
Slide 18: Summary and Outlook
Summary and Outlook Jonathan Thomas 18 16/08/2026 Optima Health | Commercial in Confidence
Slide 19: Summary & Outlook
Summary & Outlook UK leader by size in corporate health and wellbeing sector serving public and private sectors Large and growing market with attractive dynamics, and natural adjacencies Strong organic new business momentum - £10.8m ACV won in FY26 + £8.6m won or preferred bidder since the period en
Slide 20: Q&A
Q&A 20 16/08/2026 Optima Health | Commercial in Confidence
Slide 21: Appendix
Appendix 21 16/08/2026 Optima Health | Commercial in Confidence
Slide 22: ESG
ESG 22 16/08/2026 Optima Health | Commercial in Confidence
Slide 23: Technical Guidance
Technical Guidance • Exceptional costs – Expected integration and restructuring costs, principally associated with the integration of PAM and FY27 Guidance ongoing transformation activity – Includes redundancy, duplicate operating costs, property rationalisation and IT/integration expenditure Except
Slide 24: Slide 24